Generic drugmaker Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg. The approved ...

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has issued 11 observations after an inspection at Raleigh Plant, North Carolina, USA, owned by ...

Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received successful trial results for its new bone treatment medicine. The drug, called BP16, is a biosimilar of an existing ...

Intimation of completion of US FDA inspection at Raleigh Plant, North Carolina, owned by Aurolife Pharma LLC, a wholly owned stepdown subsidiary of the Company.

The US Food and Drug Administration (USFDA) had conducted inspection at the plant from March 24, 2025, to April 10, 2025, Aurobindo Pharma said in a regulatory filing.

Lisha had been prescribed medication for her mental health - including diazepam and mirtazapine - and had been in contact with the York Community Mental Health Team on multiple occasions.

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...

India’s largest drugmaker, Sun Pharma, earned 32 per cent of its total revenue from US sales. Other major Indian companies like Dr Reddy’s, Aurobindo Pharma, Zydus Lifesciences, and Gland Pharma also ...

Leading companies like Sun Pharma, Dr Reddy’s, Aurobindo Pharma, Zydus Lifesciences and Glad Pharma reportedly earn 30 to 40 per cent of their revenue from the US market. The upcoming tariffs will ...

Firms like Dr Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma and Gland Pharma reportedly earn anywhere from 30-50 per cent of their total revenues from the American market. Experts have ...

Gland Pharma topped the losses with a drop of almost 6 per cent, followed by Aurobindo Pharma, which fell by almost 5 per cent. Biocon's shares fell more than 4 per cent, and Sun Pharma, Lupin, Laurus ...